Advertisement
Screener

CRONOS GROUP INC. (CRON) Payments to Acquire Interest in Joint Venture

2.2 / 5 stars · 30/68 Roast Me

CRONOS GROUP INC. Payments to Acquire Interest in Joint Venture

CRONOS GROUP INC. (CRON) reported Payments to Acquire Interest in Joint Venture of $4.71 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireInterestInJointVenture · last filed 2022-03-01

  • CRONOS GROUP INC. payments to acquire interest in joint venture for the quarter ending 2020-12-31 was $44.65M, a 5.01% increase year-over-year.
  • CRONOS GROUP INC. payments to acquire interest in joint venture for the quarter ending 2020-09-30 was $0.00.
  • CRONOS GROUP INC. payments to acquire interest in joint venture for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
  • CRONOS GROUP INC. payments to acquire interest in joint venture for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
  • CRONOS GROUP INC. payments to acquire interest in joint venture for fiscal 2021 was $4.71M, a 89.46% decline from fiscal 2020.
  • CRONOS GROUP INC. payments to acquire interest in joint venture for fiscal 2020 was $44.65M, a 23.64% decline from fiscal 2019.
  • CRONOS GROUP INC. payments to acquire interest in joint venture for fiscal 2019 was $58.47M, a 991.30% increase from fiscal 2018.
  • CRONOS GROUP INC. payments to acquire interest in joint venture for fiscal 2018 was $5.36M.
Period endPayments to Acquire Interest in Joint Venture 3 monthPayments to Acquire Interest in Joint Venture 6 monthPayments to Acquire Interest in Joint Venture 9 monthPayments to Acquire Interest in Joint Venture 12 monthPayments to Acquire Interest in Joint Venture 12 month as first filed
2021-12-31$4.71M
10-K · filed 2022-03-01
2020-12-31$44.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$44.65M
derived: sum of 2 quarters · filed 2022-03-01
$44.65M
derived: sum of 3 quarters · filed 2022-03-01
$44.65M
10-K · filed 2022-03-01
$0.00
10-K · filed 2021-02-26
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$0.00
derived: sum of 2 quarters · filed 2020-11-05
$0.00
10-Q · filed 2020-11-05
$42.52M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$0.00
10-Q · filed 2020-08-06
$42.52M
derived: sum of 3 quarters · filed 2022-03-01
$42.48M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$0.00
10-Q · filed 2020-05-08
$42.52M
derived: sum of 2 quarters · filed 2022-03-01
$42.48M
derived: sum of 3 quarters · filed 2022-03-01
$46.58M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$42.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$42.48M
derived: sum of 2 quarters · filed 2022-03-01
$46.58M
derived: sum of 3 quarters · filed 2022-03-01
$58.47M
10-K · filed 2022-03-01
$15.13M
10-K/A · filed 2020-03-30
2019-09-30-$39.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$4.06M
derived: sum of 2 quarters · filed 2020-11-05
$15.95M
10-Q · filed 2020-11-05
2019-06-30$4.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$15.99M
10-Q · filed 2020-08-06
2019-03-31$11.89M
10-Q · filed 2020-05-08
2018-12-31$5.36M
10-K · filed 2021-02-26
2017-12-31$0.00
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87